HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia

Autor: Sandro Orru, Marcello Trucas, Giovanni Caocci, Giorgio La Nasa, Roberto Cusano, Sara Lai, Carlo Carcassi, Marianna Greco, M Arras, Elisabetta Abruzzese, Bruno Martino, Roberto Littera, Olga Mulas, Sara Galimberti
Rok vydání: 2017
Předmět:
Zdroj: Leukemia Research. 61:1-5
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2017.08.005
Popis: The human leukocyte antigen-G (HLA-G) gene encodes a tolerogenic protein known to promote tumor immune-escape. We investigated HLA-G polymorphisms and soluble molecules (sHLA-G) in 68 chronic myeloid leukemia (CML) patients. Patients with G*01:01:01 or G*01:01:02 allele had higher value of sHLA-G compared to G*01:01:03 (109.2 ± 39.5 vs 39.9 ± 8.8 units/ml; p = 0.03), and showed lower event free survival (EFS) (62.3% vs 90.0%; p = 0.02). The G*01:01:03 allele was associated with higher rates and earlier achievement of deep molecular response (MR)4.5 (100% vs 65%, median of 8 vs 58 months, p = 0.001). HLA-G alleles with higher secretion of sHLA-G seem associated with lower EFS, possibly because of an inhibitory effect on the immune system. Conversely, lower levels of sHLA-G promoted achievement of MR4.5, suggesting increased cooperation with immune system.
Databáze: OpenAIRE